$ETST Dr. Michel Aube, ETST’s CEO & CSO opines, “we have selected the research center that will conduct the in vitro assays to demonstrate the efficiency of the nutraceuticals in the ETST product pipeline which are based on the company’s International Provisory Patent Application.”